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Abstract
Inadequate sleep has become endemic, which imposes a substantial burden for public health and safety. At present, there
are no objective tests to determine if an individual has gone without sleep for an extended period of time. Here we describe
a novel approach that takes advantage of the evolutionary conservation of sleep to identify markers of sleep loss. To begin,
we demonstrate that IL-6 is increased in rats following chronic total sleep deprivation and in humans following 30 h of
waking. Discovery experiments were then conducted on saliva taken from sleep-deprived human subjects to identify
candidate markers. Given the relationship between sleep and immunity, we used Human Inflammation Low Density Arrays
to screen saliva for novel markers of sleep deprivation. Integrin aM (ITGAM) and Anaxin A3 (AnxA3) were significantly
elevated following 30 h of sleep loss. To confirm these results, we used QPCR to evaluate ITGAM and AnxA3 in independent
samples collected after 24 h of waking; both transcripts were increased. The behavior of these markers was then evaluated
further using the power of Drosophila genetics as a cost-effective means to determine whether the marker is associated
with vulnerability to sleep loss or other confounding factors (e.g., stress). Transcript profiling in flies indicated that the
Drosophila homologues of ITGAM were not predictive of sleep loss. Thus, we examined transcript levels of additional
members of the integrin family in flies. Only transcript levels of scab, the Drosophila homologue of Integrin a5 (ITGA5), were
associated with vulnerability to extended waking. Since ITGA5 was not included on the Low Density Array, we returned to
human samples and found that ITGA5 transcript levels were increased following sleep deprivation. These cross-translational
data indicate that fly and human discovery experiments are mutually reinforcing and can be used interchangeably to
identify candidate biomarkers of sleep loss.
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Introduction
During the last decade it has become clear that insufficient sleep
increases the susceptibility of individuals to serious diseases,
including obesity, type II diabetes and coronary heart disease to
name but a few [1–3]. Moreover, sleep loss results in substantial
deficits in cognition such that inadequate sleep is considered to be
a causal factor in many occupational and motor vehicle accidents
[4,5]. Indeed, sleep deprivation can impair performance to a
similar level as that observed in subjects with a blood alcohol
concentration of 0.10% [6]. Taken together with the observation
that 20–40% of adults sleep less than 7 h/night [7], these data
indicate that inadequate sleep imposes a substantial burden on
public health and safety, and that efforts to mitigate these negative
outcomes would be facilitated if an objective method to identify
sleep-deprived individuals was available[5,8].
Using the power of Drosophila genetics, we have identified
transcripts, including Amylase, that are tightly linked with sleep
homeostasis in the fly but are unchanged when episodes of
extended-waking are not accompanied with subsequent increases
in sleep (sleep rebound) [9]. Follow-up translational studies
revealed that Amylase levels are also significantly increased in
human saliva following a night of sleep loss [9]. The increase in
Amylase could not be attributed to stress in either the fly or the
human. Consistent with this observation, humans with reduced
adenosine deaminase activity show enhanced slow wave sleep,
increased feelings of being sleepy, impaired performance on the
psychomotor vigilance task (PVT) and elevated levels of salivary
Amylase activity [10]. Similarly to Amylase, transcript levels of
Filamin-A, Malic enzyme and TSC22D were first identified as
responsive to sleep loss in flies and subsequently found to be
modified in sleep deprived humans [11,12]. Thus, the fly can be
used to identify sleep-loss related transcripts as a starting point to
identify salivary biomarkers of sleep loss in humans (Figure 1).
Given that genes are pleiotropic and that the genetic and
environmental context of a gene can influence its behavior, it is
unlikely that single transcript will be able to uniquely identify sleep
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deprived individuals [13–15]. As a consequence, an effective test of
sleep loss will likely require a panel of biomarkers that both
respond to increased wake time and have a different spectrum of
outside influences (e.g., illness, metabolism, sympathetic tone, etc.).
Since components of the human salivary transcriptome are
responsive to increased wakefulness [9,11,12] we hypothesized
that we could screen for additional candidate biomarkers of sleep
loss directly in humans, and then, using a cross-translational
approach, validate these candidates using the numerous genetic
and pharmacologic protocols in the fly to determine if the
biomarkers reflect sleep need [9,13] (Figure 1). However, since
human saliva contains as many as 3000 transcripts [16], the first
question we needed to address was where should we begin? Since,
immune-related molecules have been strongly implicated for their
involvement in sleep regulation in both mammals and flies [17,18],
and serum inflammatory markers are highly responsive to sleep
disruption[19,20], we hypothesized that 1) mRNAs associated with
inflammatory molecules would be significantly elevated in human
saliva following sleep loss and 2) that when evaluated in flies, these
inflammatory molecules would only be elevated in flies following
episodes of waking that are accompanied by a sleep rebound.
Materials and Methods
Rodent Studies
Subjects. 20 male Sprague Dawley rats, 7 rats exposed to
Total Sleep Deprivation (TSD), 6 yoked controls (TSC), and 7
home cage controls (HCC). Rats weighed 464612 g (SEM) at
surgery. The rats were individually housed at 25+/21uC under
constant light for two weeks to avoid confounding subsequent sleep
loss with shifts in phase, period or amplitude of circadian rhythms
[21]. Food and water were available ad libitum.
Surgery. Rats were pre-treated with atropine sulfate (i.p.,
0.1 mL) and anesthetized with Nembutal (i.p., 1.1 mg/kg).
Surgical procedures have been previously described [22]. Briefly,
two miniature screw EEG electrodes were placed through the skull
at lateral sites, two screw electrodes were placed near the midline
to record hippocampal ‘‘theta’’ activity, and stainless steel wire
(Model A3632, Cooner Wire Co., Chatsworth, CA) was sutured
into the nuchal muscle to record electromyogram (EMG).
Apparatus and Variables Measured. After one week of
postoperative recovery, rats were placed into the deprivation
apparatus for a 7-day baseline period consistent with previous
studies [23]. TSD and TSC rats were connected by a recording
cable to a commutator suspended from a counterbalanced boom
that allowed them free movement throughout individual plastic
cages. A single horizontal fiberglass disk (46 cm diameter) partially
extended under both cages to form the floor, which was suspended
over 2–3 cm deep water. Electrophysiological signals were passed
sequentially from the rat to a polygraph, and to an AIM-65
microcomputer, where they were rectified and integrated. During
the deprivation period, the disk was rotated when sleep onset was
detected in the TSD rat, forcing both the TSD and TSC rats to
move to avoid the water. However, the TSC rat could sleep when
the disk was still. The PASS scoring system computer scored
30 sec epochs for wake, Rapid Eye Movement (REM) sleep and
three Non-REM (NREM) sleep stages: low EEG amplitude (LS),
medium EEG amplitude (HS1), and high EEG amplitude (HS2)
NREM sleep. Body weight, food intake, and water intake were
measured daily. Energy expenditure (EE) was calculated from the
caloric value of food eaten and a running average of the caloric
value of weight change (energy storage). This method has been
previously validated in TSD rats [24].
Blood collection and Cytokine analysis. After 8 days of
TSD, rats were deeply anesthetized with pentobarbital (55 mg/
kg). The thoracic cavity was opened and 5 mL of blood was
collected from the heart under sterile conditions. Blood culture
bottles (tryptic soy broth and CO2, DIF-CO Blood Culturing
System: DIFCO Laboratories, Detroit, MI) were inoculated with
3 mL of blood. The remaining 2 mL of blood was placed into
chilled Vacutainer tubes (Becton- Dickinson, Franklin Lakes, NJ),
centrifuged, and the serum was stored in aliquots at 270uC until
the day of analysis.
Blood culture bottles were vented and incubated for 24 hrs. at
37uC, visually examined, subcultured to three media–MacConkey
(for Gram-negative bacilli), CAN (for Gram-positive cocci), and
blood agar plates (TSA with 5% sheep blood for Gram-positive
Figure 1. Overall strategy to exploit the evolutionary conservation of sleep to identify and validate biomarkers of sleepiness.
doi:10.1371/journal.pone.0061016.g001
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cocci and both Gram- positive and Gram–negative bacilli) –and
incubated for another 24 hours at 37uC. Microbes were identified
in accordance with standard microbiological techniques using
Gram stains, the Analytical Profile Index (BioMerieux Vitek,
Hazelwood, MD), and other biochemical tests as needed. Negative
cultures were reported after 7 days of incubation, consistent with
standard procedure.
Serum concentrations of Tumor Necrosis Factor alpha (TNFa),
Interleukin beta (IL-1b), Interferon gamma (INF-c) were deter-
mined using commercial ELISA kits (Biosource, Camarillo, CA).
Rat Interleukin-6 (IL-6) was quantified using mouse ELISA kit
(R&D Systems, Minneapolis, MN) which has been reported to
cross-react with rat IL-6. All assays were performed in duplicate.
All blood work, including detection of bacteria and ELISA was
performed by the RH Rust Diagnostic Laboratory (Animal
Resource Center, University of Chicago).
Data Analysis. In evaluating the differences between TSD,
TSC, and Home Cage Controls (HCC) rats, food intake, body
weight, and EE was expressed as percent of baseline. All variables
were evaluated by simple analysis of variance.
Human Studies
Subjects. Nine healthy human adult volunteers (seven men
and two women), 3763.3 years of age with a BMI of 2561.4 and
with no history of neurological or psychiatric disease were enrolled
in the study after providing their consent. The study was approved
by the Institutional Review Board at Washington University
School of Medicine. Sleep time was monitored for the week prior
to the onset of the study using actigraphy to confirm adequate
baseline sleep prior to entry into the study (Actiwatch 64, Mini
Mitter Bend, OR, USA). The subjects arrived at the Washington
University Sleep Laboratory at ,7:30 AM and were constantly
monitored by two experienced, registered sleep technologists
throughout the remainder of the study. Every 6 h, the Stanford
Sleepiness Scale (SSS) and a 10-minute version of the Psychomo-
tor Vigilance Test PVT [25] were administered following which
saliva was collected using plain (non-citric acid) cotton Salivettes
(Sarstedt, Newton, NC) with 1 mL of RNALater (Qiagen).
Samples were immediately frozen on dry ice and kept at 280uC
until assayed. Meals were not allowed 1 hour prior to saliva
collection and caffeine intake was not permitted. Samples from our
previous study (n = 8) [9] were combined with the current subjects
for the evaluation of salivary IL-6.
Salivary IL-6. Quantification of IL-6 was carried out using
ELISA designed to detect human IL-6 according to manufacturer
instructions (R&D Systems, Minneapolis, MN).
Quantitative PCR. For preparation of cDNA from saliva,
salivettes were thawed and saliva was extracted by centrifugation.
RNA was isolated from cell-free supernatant as previously
described [9]. Isolated RNA was reverse-transcribed by using
SuperScript III (Invitrogen Life Technologies, Carlsbad, CA)
according to the manufacturer’s instructions. Quantitative PCR
using SYBR based technology was performed by using the 7600
Real-Time PCR System (Applied Biosystems, Foster City, CA). A
9-ul aliquot of the cDNA was used in each reaction, and all
reactions were performed in duplicate. For quantitation of saliva
samples, CT values were set and then normalized to b-actin within
the respective sample. Subsequently, normalized values were
compared between samples. Predesigned Inflammation Low
Density Arrays were purchased from Applied Biosystems Inc.
(catalog # 4378707). mRNA levels were quantified at 2 pm under
baseline conditions and at 2 pm the next day following 30 h of
extended waking. Low Density Arrays were processed according
to manufacturer’s instructions.
Fly Studies
Subjects. Flies were reared in standard laboratory conditions:
12:12 light:dark schedule, standard food (yeast, sucrose, dark corn
syrup, molasses, and agar), 25uC and 50% humidity. Wild-type
Canton S (CS) were obtained from the Bloomington Stock Center.
timeless (yw, tim01) [26] and cycle (cyc01, ry506) [27] mutants were a gift
from Jeff Hall (Brandeis). For experimentation, newly eclosed
adult flies were collected under CO2 anesthesia and segregated by
gender.
Drosophila sleep recording. Three-day-old flies were
placed into 65 mm glass tubes containing standard lab food and
monitored with the Trikinetics activity-monitoring system (Wal-
tham, MA) as previously described [28,29]. Briefly, activity was
recorded in 1 min bins and episodes of quiescence $5 min have
been empirically defined as sleep. Total sleep time, sleep
architecture and sleep homeostasis were calculated using an in-
house program according to criteria previously established [28–
30]. Flies were sleep deprived using the sleep-nullifying apparatus
(SNAP) which asymmetrically tilted 260u to +60u such that the
sleeping flies were displaced during the downward movement 6
times/minute [28,29]. Flies were deprived of sleep for 12 h
between ZT12 (lights out) to ZT0 (lights on) at which point flies
were released into recovery where they remained unperturbed for
48 h. The clock mutants cyc01 and tim01 were maintained and sleep
deprived for 7 hrs. under constant darkness. Sleep homeostasis
was calculated for each individual as a ratio of the minutes of sleep
gained above baseline during the 48 h of recovery divided by the
total min of sleep lost during 12 h of sleep deprivation (min
gained/min lost).
Pharmacology. All drugs were dissolved into standard fly
food and flies were manually transferred to tubes with the
appropriate pharmacologic agent. After two days of baseline,
female flies were placed onto 20 mM paraquat for 16 hours ending
at lights on. To differentially induce waking, flies were placed onto
either 2.5 mg/mL caffeine or 0.5 mg/mL methamphetamine for
14 hours ending at lights on [9]. Flies were then transferred back
to standard food to assess sleep.
Quantitative PCR. Total RNA was isolated from 14–20 fly
heads by using TRIzol (Invitrogen, Carlsbad, CA) following the
manufacturer’s protocol. After SD, two-thirds of the flies from
each group were frozen, and RNA was extracted from whole
heads. The remaining flies (one-third) were monitored for an
additional 24 h to assay the size of the homeostatic response. By
using this protocol, both gene expression and behavior can be
evaluated in siblings that have been exposed to identical
environments and experimental manipulations. RNA was treated
with RNase-free DNase I (TURBO DNA-free; Ambion, Austin,
TX) according to the manufacturer’s instructions. Isolated RNA
was reverse-transcribed by using SuperScript III (Invitrogen Life
Technologies, Carlsbad, CA) according to the manufacturer’s
instructions. Quantitative PCR using SYBR based technology was
performed by using the 7600 Real-Time PCR System (Applied
Biosystems, Foster City, CA). A 9-ul aliquot of the cDNA was used
in each reaction, and all reactions were performed in duplicate. To
minimize cDNA variability between samples, cDNA sets were
chosen by matching RP49 levels. Quantitative values were
calculated using the 2-ddCT method [31]. Briefly, CT values
were set and then normalized to the control gene, RP49, within the
respective sample. Subsequently, normalized values were com-
pared between samples.
Salivary Marker of Sleep Deprivation
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Results
IL-6 levels are increased following Sleep deprivation in
rats and humans
Recent studies have shown that sleep disruption in humans
produces enhanced inflammatory signaling as evidenced by
increases in serum interleukin-1b (IL-1b), interleukin-6 (IL-6),
tumor necrosis factor-alpha (TNF-a), and C-reactive protein
(CRP) to name a few [32,33]. To determine if serum levels of
cytokines are also changed in rats in response to sleep deprivation,
we evaluated serum levels of TNF a, IL-1b, and INFc and IL-6
following 8 days of total sleep deprivation using the disk-over-
water method. During sleep deprivation, TSD rats lost an average
of 72% of their daily NREM and 96% of their daily REM sleep. In
contrast, TSC rats lost only 20% of their daily NREM and 47% of
their daily REM sleep. Furthermore, TSD rats lost more weight
and increased food intake to a larger degree than TSC rats (Figure
S1 A,B) such that TSD rats exhibited a significant increase in
Energy Expenditure (EE) (Figure 2 A). Consistent with previous
reports [34] bacteria was present in the blood of 2 of 7 TSD rats
(Rat 1-Pseudonomas aerguinosa and Streptocomyces agalactiae; Rat 2-staph
Sciuri/lentus, strep equisinailes, corynebacterium minaticsimum), 1 of 6 TSC
rats (staph hyicus, enterococaus sp.), and 0 of 7 HCC rats. There was no
apparent effect of the presence of bacteria on weight, food intake,
or EE. Of the cytokines evaluated, only IL-6 was significantly
increased following 8 days of TSD (Figure 2B,C). We found no
statistical differences in serum levels of TNF-a, IL-1b, and INF-c
(Figure S2). Thus, chronic total sleep deprivation increases the
pro-inflammatory cytokine IL-6 (although see [35]).
While human studies have found that IL-6 levels are increased
in serum following sleep deprivation, sleep restriction and
insomnia [36–41], it remains unclear whether salivary IL-6 levels
are modified by sleep disruption. Given that saliva is a readily
accessible biofluid that can be assayed using non-invasive
procedures we examined the effects of a night of sleep loss on
salivary IL-6 after 30 h of wakefulness. Subjects were admitted to
the laboratory at 8 am and were administered the Stanford
Sleepiness Scale (SSS), a 10-min version of the psychomotor
vigilance task (PVT) and provided a saliva sample. Subjects
completed the SSS and the PVT and gave saliva samples every 6 h
until 2 pm the following day. As seen in Figure 3A, subjective
sleepiness was significantly increased following 30 h of waking.
Moreover, sleep deprived subjects displayed an increase in the
number of lapses and their reaction times were significantly slower
(Figure 3B–D). Thus, our sleep deprivation protocol increased
perceived sleepiness and decreased reaction time performance. IL-
6 levels were increased following 30 h of sustained waking
compared to untreated circadian-matched controls (Figure 3E).
These data are consistent with previous observations that IL-6
levels are increased in serum following sleep loss and suggests
salivary IL-6 may be an appropriate tool to elucidate the
relationship between sleep disruption, perceived sleepiness and
IL-6 activation.
Sleep loss activates inflammatory signaling in flies and
humans
Microarray studies have reported that sleep deprivation
increases transcript levels of genes involved in immunity
[12,18,42]. However, the extent to which immune-related genes
are associated with increased sleep-drive/sleepiness remains
unknown. In flies, increased sleep drive/sleepiness is operationally
defined as the presence of sleep homeostasis following extended
waking [9]. As seen in Figure 4A and Table S1, 12 h of sleep
deprivation alters mRNA levels of several genes associated with
the immune response; some by as much as 80–130 fold. To
determine whether the increase in immune-related transcripts was
due to sleep loss per se, or if these genes were non-specifically
activated by the methods used to keep the animals awake (e.g.
mechanical perturbation), we profiled immune-related genes in
flies that spontaneously exhibit fragmented sleep. We have
previously shown that a sub-population (,8%) of Cs flies
spontaneously exhibit fragmented sleep, as defined by nighttime
sleep bout durations less than 30-min, but obtain normal amounts
of total sleep [43]. Despite obtaining the same amount of total
sleep as their consolidated siblings, these sleep-fragmented flies
behave similarly to sleep deprived flies as measured by deficits in
dopamine signaling, increases in the biomarker of sleepiness,
Amylase, and impaired short-term memory [43]. As seen in
Figure 4B and Table S1, in the absence of mechanical
perturbation, spontaneously sleep-fragmented flies show similar
increases in immune-related genes to that observed in sleep-
deprived flies. Importantly, when flies were subjected to oxidative
stress, by feeding them paraquat, immune related transcripts were
not consistently elevated (Table S1 and Figure S3). Taken
together, these data demonstrate that the increases in immune-
related transcripts that are observed following sleep deprivation
are not due to a general stress response.
Figure 2. IL-6 is elevated in serum of chronic total sleep deprived rats. (A) Energy Expenditure expressed as % of home cage controls (HCC,
n = 7) is significantly increased in total sleep deprived (TSD, n = 7) rats compared to yoked controls (TSC, n = 6); One way ANOVA F(2,11) = 6.79, p = .012,
* modified Bonferroni test p,0.05 (B) Serum concentrations of IL-6 protein from individual TSD, TSC, and HCC rats. Arrows denote which animals
tested positive for bacteria. (C) Mean concentration of IL-6 from individual rats in (B). One way ANOVA F(2,17) = 5.22, p = .017 * p,0.05 modified
Bonferroni test [58]. Data are presented as mean6SEM.
doi:10.1371/journal.pone.0061016.g002
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To evaluate the extent to which immune-related genes are
associated with increased sleep drive, rather than simply being
elevated during extended waking, we exposed the circadian clock
mutant, cycle (cyc01), with either 7 h of sleep deprivation or 7 h of
starvation. cyc01 mutants are extremely sensitive to sleep loss and
exhibit a sleep rebound that is 10 times greater than wild-type flies
even following brief periods of sleep deprivation [29]. However,
episodes of waking induced by starvation are not accompanied by
1) a sleep rebound, 2) increases in Amylase or 3) deficits in short-
term memory [44,45]. Thus, if immune-related transcripts are
indeed biomarkers of sleepiness, they should be activated by sleep
deprivation but not by starvation. As seen in Figure 5A and Table
S2, several immune related genes are altered when waking is
induced by sleep deprivation but not when waking is induced by
starvation. In contrast to cyc01, timeless mutants (tim01) do not
display a sleep rebound following 3 h and 6 h of sleep deprivation
but show clear signs of sleep homeostasis following 9 and 12 h of
sleep deprivation [9,29,46]. Thus if immune-related transcripts are
associated with periods of waking that are accompanied by
elevated sleep drive, we would predict that immune-related
transcripts would only be elevated in tim01 mutants following 9
and 12 h of sleep deprivation. As seen in Figure 5B and Table S2,
many of the immune genes, including Attacin-B (AttB), Metchnikowin
(Mtk), Drosocin (Dro) and Drosomycin (Drs) followed the expected
stepwise increase of expression in tim01 mutants following 9 and
12 h of sleep loss. Thus, the increase in immune-related transcripts
is associated with sleepiness and not simply wake time.
As mentioned above, an effective test of sleep loss in humans will
likely require a panel of biomarkers that 1) respond to increased
wake time and 2) have different spectrums of outside influences.
Given that immune-related genes appear to be tightly associated
with increased sleepiness in flies and that sleep disruption increases
serum inflammatory markers in humans, we conducted an
unbiased screen of 96 inflammation-related genes using Human
Taqman Low Density Arrays. Saliva samples from the subjects in
Figure 3 were evaluated at 2 pm under baseline and at 2 pm after
30 h of waking such that each subject served as their own
untreated circadian-matched control. Salivary mRNA for one
subject was substantially degraded and was excluded from further
analysis. We predicted that since the number of transcripts that
can be found in saliva is relatively small [16], only a subset of the
genes on the Low Density Array would be present in human
saliva. Indeed, only 18/96 genes were present in 6 or more of the 7
subjects (Table S3). Interestingly, Anaxin 3 (ANXA3) and Integrin aM
(ITGAM) were significantly elevated following 30 h of waking
(Figure 6 A,B). Because this was a screen to identify new candidate
biomarkers we chose not to correct for multiple comparisons in the
initial analysis. However, as an alternative to making a correction
for multiple comparisons, we conducted additional tests to
determine if the changes in ANXA3 and ITGAM were
reproducible. We designed new primers for each gene and
evaluated their transcript levels using Syber Green, a different
technology than the Taqman based Low Density Array. We then
evaluated independent saliva samples from each subject after 24 h
of waking. As seen in Figure 7A–D, subjects reported feeling sleepy
and had significantly more lapses and slower reaction times on the
PVT after 24 h of waking. Importantly, both ANXA3 and ITGAM
were significantly increased after 24 hours of sleep deprivation
(Figure 7E–F). Thus, transcripts for ANXA3 and ITGAM are
elevated in human saliva during sleep loss.
Figure 3. Human subjects show an increase in salivary IL-6. (A) Subjective sleepiness as assessed using the Stanford Sleepiness Scale was
increased following 30 h of wakefulness. Each subject served as their untreated circadian-matched control; t-test p = 0.0008. (B–D) Cognitive
performance, assessed using the psychomotor vigilance task (PVT), was impaired following 30 h of wakefulness: (B) Lapses increased during waking
compared to controls; t-test, p = 0.03. (C) Mean reaction time, expressed as 1/RT) slowed; t-test p = 0.001. (D) Reaction times in the slowest 10% also
slowed t-test p = 0002. (E) Levels of IL-6 protein from human saliva after 30 hours of waking. Levels in sleep deprived subjects (n = 16) are expressed
as a % of that their own untreated circadian-matched sample (con); t-test p = 0.042.
doi:10.1371/journal.pone.0061016.g003
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Given that the sample size of the human sleep deprivation study
is relatively small, we re-turned to the fly to determine whether
transcripts of the Drosophila homologues of ITGAM would behave
as biomarkers of sleepiness. As seen in Figure 8, the transcript
levels of two closely related homologs (http://eugenes.org/),
multiple edematous wings (mew) and inflated (if), did not behave as a
biomarkers when evaluated using the paradigms used to validate
Amylase and immune-related genes described above (Figure 5). For
comparison, we present a cartoon of idealized data depicting the
pattern of expression of a biomarker of sleepiness in Figure 8 A–C.
Although this outcome was disappointing, it widely recognized
that under some circumstances genes can display complementary
expression profiles in flies and mammals. For example, in
Drosophila, transcripts for the circadian-clock gene Clock exhibit a
circadian pattern of expression while transcripts for cycle are stable
across the circadian day; in contrast transcripts for the mammalian
homologue of cycle, Bmal, exhibit a circadian pattern while CLOCK
transcript levels remain stable. This observation suggested to us
that, in the fly, alternate members of the integrin family might be
responsive to sleep loss. Therefore, we also examined the
expression profiles of scab (scb), aPS5, aPS4, myospheriod, and bn
integrin using protocols that can disassociate wake time from sleep
drive [9]. As seen in Figure 9 and Table S4, only transcript levels
of scb were associated with elevated sleepiness. That is, in cyc01
mutants, scb transcripts were significantly increased following 7 h
of sleep deprivation but were not changed when 7 h of waking was
induced by starvation. Since previous studies have shown that a
sleep rebound is observed following waking induced by caffeine
but not waking induced by methamphetamine administration
[9,28,46,47], we evaluated scbmRNA in wild-type flies fed caffeine
and methamphetamine. As seen in Figure 9B, scb transcript levels
were significantly increased when waking was induced by caffeine
Figure 4. Transcripts for immune-related genes are elevated in flies under conditions of increased sleepiness. (A) Immune-related
transcripts are significantly elevated in Cs flies following a night of sleep deprivation; data are expressed as % of untreated circadian-matched siblings.
(B) Cs flies with normal total sleep time but spontaneously fragmented sleep (average night sleep bouts ,30 min) exhibit an increase in immune-
related transcripts expressed as % change from siblings with consolidated sleep and matched by total sleep time; error bars are present but not
visible given the magnitude of the changes. Abbreviations: Drosocin (Dro), Attacin-B (AttB), Drosomycin (Drs), Metchnikowin (Mtk), Immune induced
molecule 23 (IM23), and Defensin (Def).
doi:10.1371/journal.pone.0061016.g004
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but not when waking was induced by methamphetamine. Finally,
we evaluated scb in tim01 flies after 3, 6, 9, and 12 hours of sleep
deprivation. scb displayed a stepwise increase at 9 and 12 hours of
sleep deprivation (Fig 9C and Table S5). Together these data
indicate that while the Drosophila homologues of ITGAM, mew and
if, do not behave as biomarkers, scb is consistently increased
following waking episodes that are accompanied by a sleep
rebound. Interestingly, a human homologue of scb (http://
eugenes.org/), Integrin a5 (ITGA5), is not included on the Taqman
Low Density Array. Thus, we asked whether salivary transcripts of
ITGA5 would be responsive to 24 h and 30 h of waking. As seen in
Figure 9E, ITGA5 transcription was significantly elevated at 30 h.
Together, these data indicate that fly and human discovery
experiments are mutually reinforcing and can be used inter-
changeably to identify candidate biomarkers of sleep loss.
Discussion
Given the burden that inadequate sleep and sleep disorders
place on society, there is consensus of the need for a simple,
inexpensive and objective measure of sleep loss [8]. Although
assays based upon electrophysiological measurements, pupillom-
etry and several behavioral tests, most notably the psychomotor
vigilance test, have shown promise, these methods have been
difficult to transfer into the field and into occupational settings
where they might have the largest impact on public health and
safety [5,8]. We have hypothesized that as a rich and easily
Figure 5. Immune-related transcripts are associated with increased sleep drive in Drosophila clock mutants. (A) Immune related
transcripts are substantially increased in cyc01 mutants following 7 h of sleep deprivation but are not consistently activated when 7 h of waking is
induced by starvation; data are expressed as % change from untreated siblings. Experiments were conducted in constant darkness (DD). (B–E)
Transcript levels for AttB, Dro, Mtk and Drs in tim01 mutants following 3, 6, 9 and 12 h of sleep deprivation. Immune related transcripts are consistently
elevated following 9 and 12 hour sleep deprivation (Light Green) but not after 3 or 6 h of sleep deprivation when no sleep rebound is observed (dark
Green).
doi:10.1371/journal.pone.0061016.g005
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accessible biofluid, saliva can be mined to identify analytes that are
responsive to sleep loss [13]. Moreover, since we expect that an
effective test of sleep loss will likely be composed of a panel of
multiple biomarkers, it is important to identify and validate a
number of candidates that have a different spectrum of outside
influences. Thus, a major goal of this study was to demonstrate the
feasibility of conducting an unbiased screen using saliva to identify
analytes that respond to sleep deprivation. Since the relationship
between sleep and the immune system has been the topic of
intensive investigations for over 25 years [17], we began by
interrogating the salivary transcriptome to determine whether
immune related genes are modified by sleep loss. We then
exploited the evolutionary conservation of sleep to further
characterize the behavior of candidate biomarkers using Drosophila
genetics. Our data indicate that IL-6, ITGAM, ANAX3, and ITGA5
are candidates for inclusion in a panel of salivary biomarkers of
sleep loss in humans.
We became interested in examining the effects of sleep
deprivation on salivary IL-6 based upon previous observations
that serum inflammatory markers are strongly modulated by sleep
disruption in humans [19,20,36]. Indeed, over the last decade
studies have consistently reported that sleep disruption is
associated with changes in serum IL-6 [48]. For example, 2 h of
sleep restriction in young healthy subjects for 1 week results in an
increase in plasma IL-6 levels in the morning and afternoon [39].
In addition, poor quality sleep enhances the daytime secretion of
IL-6 [49]. Interestingly, serum IL-6 levels are negatively correlated
with sleep quality and have also been associated with daytime
somnolence and fatigue [19,40,50]. Thus, inflammatory markers
in saliva, including IL-6, are viable candidates for monitoring sleep
disruption.
In the current study, we found that the increase in plasma IL-6
is also seen in rats following 8 days of chronic total sleep
deprivation. Interestingly, long-term sleep deprivation appears to
leave rats more susceptible to infection [51]. Nonetheless, it is
unlikely that bacteremia resulted in immune activation and IL-6
induction as only 2 of 7 rats showed bacteremia after 8 days of
chronic total sleep deprivation. One limitation of the rodent study
was that we were only able to sample IL-6 levels at one time point.
Given that IL-6 levels might change dynamically over time, a
more extensive time-course will be needed to determine when IL-6
levels are increased and whether they remain elevated during
chronic sleep loss. It is interesting to note that in the fly, there is
also an upregulation of immune genes with sleep deprivation [18].
Indeed, we extend these results to show that sleep fragmentation is
capable of inducing immune genes in the fly without the need for
mechanical perturbation to keep the animals awake. Similarly,
immune genes are not consistently activated by exposure to
oxidative stress. Importantly, we found that waking induced by
starvation, which is not associated with a sleep rebound or
Figure 6. Human Inflammation Low Density Arrays identify
genes that are increased following 30 h of waking. (A) Salivary
transcript levels for Integrin aM (ITGAM) and (B) Annexin (ANXA3) are
increased following 30 hours of wakefulness; t-test, p = .04 and p= .04,
respectively. Each subject serves as their own untreated circadian
matched control; data are expressed as a percent change from control.
doi:10.1371/journal.pone.0061016.g006
Figure 7. Twenty-four hours of waking increases salivary ITGAM
and ANXA3. (A) Subjective sleepiness (SSS) is increased following 24 h
of wakefulness. Each subject served as their untreated circadian-
matched control; t-test p = 0.0003. (B) Lapses increased during waking
compared to controls; t-test p = 0.028. (C) Mean reaction time,
expressed as 1/RT, slowed; t-test p = 0.003 (D) Reaction times in the
slowest 10% also slowed; t-test p = 0.016. (E) Salivary transcript levels
for Integrin aM (ITGAM) and (F) Annexin (ANXA3) are increased following
24 hours of waking; t-test, p = 0.04 and p=0.04, respectively; data are
expressed as a percent change from control.
doi:10.1371/journal.pone.0061016.g007
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cognitive deficits in flies [44], does not activate immune genes.
Thus, immune activation may be may be a critical component in
the response to sleep deprivation, since it is observed in rats, flies,
and humans. Moreover, our data suggest that immune activation
is a physiologic response to sleep loss and not necessarily a
secondary response to infection or stress.
Our data demonstrate that salivary IL-6 is increased in humans
following sleep loss and is consistent with studies measuring serum
IL-6. Since saliva is an easily accessible biofluid, salivary IL-6 may
eventually become useful as an additional quantitative tool for
assessing sleep loss. With this in mind, it is important to note that
both serum and salivary IL-6 are influenced by circadian rhythms
[49,52]. The circadian influence on IL-6 has two implications.
First, salivary IL-6 may not be equally effective at detecting sleep
loss at all circadian times. Although this may interfere with using
salivary IL-6 in the field, IL-6 can still be used in the laboratory
where circadian factors can be more precisely controlled [e.g.
phenotyping human subjects with polymorphisms in genes that
influence sensitivity to sleep loss [10,53] or in subjects with
differential cognitive impairments following sleep loss [54]].
Secondly, the prevalence of analytes that are influenced by
circadian rhythms suggests that it may be necessary to generate
separate panels of biomarkers that are optimized for specific
circadian times. Although this may seem less than ideal, it may
expedite the evaluation of biological tests of sleep loss that can be
used in real-world settings. In any event, salivary IL-6 is increased
following 30 h of waking and may prove to be a simple, accessible
and inexpensive marker to assess sleep loss in humans under a
variety of experimental settings.
Figure 8. Drosophila homologues of ITGAM, If andmew do not behave as biomarkers in flies. (A–C) A cartoon of idealized data of expected
transcriptional patterns exhibited by biomarkers of sleepiness for comparison to empirical data in D–I. D, G) Transcripts for if and mew are not
elevated in Cs flies when waking is induced either by caffeine (C) (which is accompanied by a sleep rebound) or methamphetamine (M) (which is not
followed by an increase in sleep) compared to untreated siblings. (E,H) cyc01 mutants do not show an increase in if ormew transcripts following sleep
deprivation. (F,I) There is no step increase in if or mew transcripts following 6 or 9 h of sleep deprivation in tim01 mutants.
doi:10.1371/journal.pone.0061016.g008
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In previous studies we have used the fly as a starting point to
identify genes that might also change their expression profile in
human saliva following sleep deprivation [9,11,12]. In the current
study, candidate genes were identified first in humans and then,
using a cross-translational approach, validated using Drosophila
genetics. It is exciting to note that several recent papers have used
the fly to validate the role of genes that were first identified in
humans [55–57]. Together with these studies our data demon-
strate that Drosophila can be used as a model organism to quickly
and efficiently understand the physiologic and behavioral impli-
cation of genes that have been identified in larger screens in
humans. Indeed, a cross-translational approach reinforces, once
again, the evolutionary conservation of sleep regulatory mecha-
nisms.
One potential weakness of this study is the low number of
human subjects. To ensure that our results are not an artifact of
sampling, we have taken several approaches to validate our initial
findings that ITGAM is upregulated in the saliva of humans sleep
deprived for 30 hours. The first was articulated above showing
that homologous genes respond similarly in Drosophila. The second
approach was to confirm that the same transcripts were elevated in
an independent sample collected after 24 hours of wakefulness
using a different strategy to quantify transcripts. Even with our low
sample number, transcripts for ITGAM and ANXA3 were elevated
at both time points using different techniques. Interestingly,
transcript levels of ITGA5, which were not on the Taqman Low
Density Array but were included based upon the behavior of
Drosophila transcripts, were elevated at 30 h and just missed being
significantly elevated (p= 0.056) at 24 h waking. Together, our
data demonstrate that inflammatory genes including ITGAM,
ANAX3, and ITGA5 are candidates for inclusion in a panel of
biomarkers of sleep loss in humans.
Supporting Information
Figure S1 (A) Mean Daily food intake and (B) Body weight in
TSD and TSC rats expressed as percentage of baseline. *p,0.05;
Data are presented as mean 6 SEM.
(TIFF)
Figure S2 (A) tumor necrosis factor a(TNFa), (B) interferon c
(INFc), and (C) interlukein-1 b (IL-1b) were not different after
sleep deprivation in rats that have been sleep deprived (TSD), their
yoked controls (TSC) and home-cage controls (HCC). One way
ANOVA F(2,17) = 1.016, p= .38, One way ANOVA F(2,17) = 1.92,
p = .17, One way ANOVA F(2,17) = 0.433, p = .64, respectively.
(TIFF)
Figure S3 The chemical inducer of stress, paraquat,
does not consistently elevate transcript levels of immune
genes. Data are presented as % of untreated controls. Cs female
flies were placed onto 20 mM paraquat or vehicle for 16 hours
Figure 9. The Drosophila integrin scb and Human ITGA5 are modified by sleep loss. (A) scb is elevated following caffeine administration but
not after waking induced by methamphetamine. (B) scb is elevated in sleep deprived cyc01 mutants but is not increased when waking is induced by
starvation. (C) scb mRNA levels remain low following deprivations that do not activate homeostatic mechanisms (3 and 6 h SD), but are elevated
following deprivations that activate homeostatic mechanisms (9 and 12 h SD). (D–E) Salivary ITGA5 transcripts are increased in humans following
30 h of wakefulness while 24 h of wakefulness do not quite reach significance; t-test and p= 0.04 and p=0.056 respectively. Each subject serves as
their own circadian matched untreated control; data are expressed as a percent change from control.
doi:10.1371/journal.pone.0061016.g009
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ending at lights on (ZT-0). Total RNA was isolated from fly heads
and evaluated using Quantitative PCR.
(TIFF)
Table S1 Transcript levels of 21 immune-related genes from the
heads of wild-type Canton S flies. Cs flies were sleep deprived for
12 hours and compared to untreated, circadian-matched siblings.
Sleep fragmented flies with nighttime sleep bouts less than 30
minutes were matched for total sleep time with siblings that
exhibited consolidated sleep. Cs flies treated with paraquat were
compared to vehicle fed controls. Data presented as fold change6
SEM.
(TIFF)
Table S2 Transcript levels of 21 immune related genes from the
heads of cyc01 and tim01 flies. cyc01 flies were sleep deprived ant
starved for 7 hrs. and values were compared to unperturbed
controls. tim01 flies were sleep deprived for 3, 6, 9, and 12 hours
and compared to unperturbed tim01 siblings. All experiments were
conducted in DD. Data presented as fold change 6 SEM.
(TIFF)
Table S3 Eighteen out of 96 genes from the Human
Inflammation Low-Density Array were detected in 6 out of the
7 subjects.
(TIFF)
Table S4 Transcriptional changes of integrins in Cs flies. Cs flies
were sleep deprived for 12 hours and compared to untreated,
circadian-matched siblings. Sleep fragmented flies with nighttime
sleep bouts less than 30 minutes were matched for total sleep time
with siblings that exhibited consolidated sleep. Cs female flies were
placed onto 20 mM paraquat or vehicle for 16 hours ending at
lights on (8 am). Total RNA was isolated from fly heads and
evaluated using Quantitative PCR. Data presented as fold change
6 SEM.
(TIFF)
Table S5 Transcript levels of integrin related genes from the
heads of cyc01 and tim01 flies. cyc01 flies were sleep deprived and
starved for 7 hrs. and values were compared to unperturbed
controls. tim01 flies were sleep deprived for 3, 6, 9, and 12 hours
and compared to unperturbed tim01 siblings. All experiments were
conducted in DD. Data presented as fold change 6 SEM.
(TIFF)
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